Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects
Open Access
- 28 June 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 100 (3) , 425-433
- https://doi.org/10.1111/j.1365-2249.1995.tb03717.x
Abstract
The CD28 receptor on CD4+ and CD8+ T cells interacts with B7 molecules on antigen-presenting cells (APC) to generate essential costimulatory signals. The cytolytic potential of CD8+ T cells could be linked to CD28 expression. Since HIV induces dysfunction of both CD4+ and CD8+ T cells, we evaluated CD28 expression and function in both subsets during HIV infection. CD28 expression on CD8+ T cells from HIV+ subjects was strongly reduced in a disease stage-related fashion. CD28-CD8+ T cells preferentially expressed CD57 and CD11b, but lacked CD26 and IL-2Rα. The CD8+ T cells from the patients showed a significantly reduced proliferative response to co-stimulation with cell-bound anti-CD3 and B7. Nevertheless, when stimulated with plate-fixed anti-CD3, CD8+ T cells from HIV-infected subjects proliferated normally, and normal levels of IL-2Rα nod transferrin-receptor could be induced on CD28-CD8+ T cells from the patients. In addition, stimulation with plate-fixed anti-CD3 induced proliferative responses in highly purified CD28-CD8+ T cells from both HIV- and HIV+ persons. Furthermore, the increased cytotoxic activity of peripheral blood mononuclear cells (PBMC) from HIV+ subjects, measured in an anti-CD3 redirected assay, was predominantly exerted by CD28-CD57+ T cells. CD4+ T cells from the patients showed a slight but significant CD28 down-regulation and were slightly hyporesponsive to B7 co-stimulation. Decrease of CD28 on CD8+ T cells from HIV+ subjects is associated with an impaired response to co-stimulation via B7. CD28-CD8+ T cells from seropositives, however, are not completely inert, since they contain in vivo activated CTL and they can be additionally activated through a B7-independent stimulation.Keywords
This publication has 28 references indexed in Scilit:
- Expression of Costimulatory Molecule CD28 on T Cells in Human Immunodeficiency Virus Type 1 Infection: Functional and Clinical CorrelationsThe Journal of Infectious Diseases, 1994
- B70 antigen is a second ligand for CTLA-4 and CD28Nature, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Functional expression of B7/BB1 on activated T lymphocytes.The Journal of Experimental Medicine, 1993
- In situ expression of B7/BB1 on antigenpresenting cells and activated B cells: an immunohistochemical studyInternational Immunology, 1993
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- Autoreactive cytotoxicity in HIV-infected individualsClinical and Experimental Immunology, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.Proceedings of the National Academy of Sciences, 1989